The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology
Open accessAbstract
Iron is an essential nutrient that plays a complex role in cancer biology. Iron metabolism must be tightly controlled within cells. Whilst fundamental to many cellular processes and required for cell survival, excess labile iron is toxic to cells. Increased iron metabolism is associated with malignant transformation, cancer progression, drug resistance and immune evasion. Depleting intracellular iron stores, either with the use of iron chelating agents or mimicking endogenous regulation mechanisms, such as microRNAs, present attractive therapeutic opportunities, some of which are currently under clinical investigation. Alternatively, iron overload can result in a form of regulated cell death, ferroptosis, which can be activated in cancer cells presenting an alternative anti-cancer strategy. This review focuses on alterations in iron metabolism that enable cancer cells to meet metabolic demands required during different stages of tumorigenesis in relation to metastasis and immune response. The strength of current evidence is considered, gaps in knowledge are highlighted and controversies relating to the role of iron and therapeutic targeting potential are discussed. The key question we address within this review is whether iron modulation represents a useful approach for treating metastatic disease and whether it could be employed in combination with existing targeted drugs and immune-based therapies to enhance their efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–246 of 246
Tissue ferritin concentration and prognosis in carcinoma of the breast
Weinstein, R. E., Bond, B. H., Silberberg, B. K., Vaughn, C. B., Subbaiah, P., & Pieper, D. R. (1989) · Breast Cancer Research and Treatment · doi:10.1007/bf01806307 · Cited by 50
CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer
Cheng, Z., Zhang, D., Gong, B., Wang, P., & Liu, F. (2017) · Oncotarget · doi:10.18632/oncotarget.20244 · Cited by 50
Iron Prevents Ferritin Turnover in Hepatic Cells
Truty, J., Malpe, R., & Linder, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105392200 · Cited by 49
Reuben, A., Chung, J. W., Lapointe, R., & Santos, M. M. (2017) · Immunity Inflammation and Disease · doi:10.1002/iid3.158 · Cited by 49
Serum Ferritin as a Clinical Markerfor Renal Cell Carcinoma: Influenc e of Tumor Size and Volume
Kırkalı, Z., Güzelsoy, M., Mungan, M. U., Kırkalı, G., & Yörükoğlu, K. (1999) · Urologia Internationalis · doi:10.1159/000030349 · Cited by 48
Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells
Łubgan, D., Jóźwiak, Z., Grabenbauer, G. G., et al. (2008) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-008-0037-2 · Cited by 48
Toshiyama, R., Konno, M., Eguchi, H., Asai, A., Noda, T., Koseki, J., Asukai, K., Ohashi, T., Matsushita, K., Iwagami, Y., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8357 · Cited by 48
Rehwald, C., Schnetz, M., Urbschat, A., Mertens, C., Meier, J. K., Bauer, R., Baer, P. C., Winslow, S., Roos, F. C., Zwicker, K., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0655-7 · Cited by 47
Chao, J., Synold, T. W., Morgan, R. J., Kunos, C. A., Longmate, J., Lenz, H.-J., Lim, D. W., Shibata, S., Chung, V. M., Stoller, R. G., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1779-5 · Cited by 46
Mehta, K. J., Coombes, J. D., Briones-Orta, M. A., Manka, P. P., Williams, R. L., Patel, V. B., & Syn, W. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.08.012 · Cited by 46
Moastafa, T. M., El‐Sisi, A. E., El-Saeed, G. K., & Koura, M. S. E.-D. (2014) · International Scholarly Research Notices · doi:10.1155/2014/184278 · Cited by 45
Zhang, W., Yao, W., Yan, Q., Ma, F., Shi, X., Zhao, Y., Peng, Y., Wang, J., & Jiang, B. (2013) · Oncology Reports · doi:10.3892/or.2013.2828 · Cited by 45
Body iron status and gastric cancer risk in the EURGAST study
Fonseca‐Nunes, A., Agudo, A., Aranda, N., Arija, V., Cross, A. J., Molina‐Montes, E., Sánchez, M., Bueno-de-Mesquita, H. B., Siersema, P. D., Weiderpass, E., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29669 · Cited by 44
Jiang, X., & Elliott, R. L. (2017) · Anticancer Research · doi:10.21873/anticanres.11567 · Cited by 44
Food, M. R., Sekyere, E. O., & Richardson, D. R. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03140.x · Cited by 43
Hu, Z., Wang, L., Han, Y. K., Li, F., Zheng, A., Xu, Y. J., Wang, F., Xiao, B., Chen, C., & Tao, Z. (2018) · Oncology Letters · doi:10.3892/ol.2018.9642 · Cited by 43
Nakamaki, T., Kawabata, H., Saito, B., Matsunawa, M., Suzuki, J. S., Adachi, D., Tomoyasu, S., & Koeffler, H. P. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04866.x · Cited by 42
Spangler, B., Fontaine, S. D., Shi, Y. H., Sambucetti, L. C., Mattis, A. N., Hann, B. C., Wells, J. A., & Renslo, A. R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01470 · Cited by 42
Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease
HANN, H.-W. L., Lange, B. J., Stahlhut, M. W., & McGlynn, K. A. (1990) · Cancer · doi:10.1002/1097-0142(19900715)66:2<313::aid-cncr2820660219>3.0.co;2-j · Cited by 40
Transferrin Receptor 1: A Target for Antibody-Mediated Cancer Therapy
Daniels‐Wells, T. R., & Penichet, M. L. (2016) · Immunotherapy · doi:10.2217/imt-2016-0050 · Cited by 40
Tesfay, L., Huhn, A. J., Hatcher, H., Torti, F. M., & Torti, S. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040030 · Cited by 39
Role of hepcidin and iron metabolism in the onset of prostate cancer
Zhao, B., Li, R., Cheng, G., Li, Z., Zhang, Z., Li, J., Zhang, G., Bi, C., Chen, H., Yang, L., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8544 · Cited by 39
Serum ferritin level is a prognostic marker in patients with peripheral T‐cell lymphoma
Koyama, S., Fujisawa, S., Watanabe, R., Itabashi, M., Ishibashi, D., Ishii, Y., Hattori, Y., Nakajima, Y., Motohashi, K., Takasaki, H., et al. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12592 · Cited by 38
DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms
Lemler, D. J., Lynch, M. L., Tesfay, L., Deng, Z., Paul, B. T., Wang, X., Hegde, P., Manz, D. H., Torti, S. V., & Torti, F. M. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0814-9 · Cited by 38
The Tumor Suppressor, P53, Decreases the Metal Transporter, ZIP14
Zhao, N., Zhang, A., Wortham, A. M., Jue, S. F., Knutson, M. D., & Enns, C. A. (2017) · Nutrients · doi:10.3390/nu9121335 · Cited by 38
Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer
Leftin, A., Ben-Chetrit, N., Klemm, F., Joyce, J. A., & Koutcher, J. A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184765 · Cited by 36
Ratner, E., Zhu, Y.-L., Penketh, P. G., Berenblum, J., Whicker, M. E., Huang, P. H., Lee, Y., Ishiguro, K., Zhu, R., Sartorelli, A. C., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.54 · Cited by 36
H Ferritin Gene Silencing in a Human Metastatic Melanoma Cell Line: A Proteomic Analysis
Sanzo, M. D., Gaspari, M., Misaggi, R., Romeo, F., Falbo, L., Marco, C. D., Agosti, V., Quaresima, B., Barni, T., Viglietto, G., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200705z · Cited by 33
Leftin, A., Zhao, H., Turkekul, M., de Stanchina, E., Manova, K., & Koutcher, J. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-11899-2 · Cited by 33
TfR2 expression in human colon carcinomas
Calzolari, A., Deaglio, S., Maldi, E., Cassoni, P., Malavasi, F., & Testa, U. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.08.001 · Cited by 32
Khodaverdian, V., Tapadar, S., MacDonald, I. A., Xu, Y., Ho, P.-Y., Bridges, A. E., Rajpurohit, P., Sanghani, B. A., Fan, Y., Thangaraju, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39214-1 · Cited by 32
Potůčková, E., Jansová, H., Macháček, M., Jirkovská, A., Hašková, P., Tichotová, L., Richardson, V., Kalinowski, D. S., Richardson, D. R., & Šimůnek, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088754 · Cited by 29
Mechanisms underlying the cytotoxic effects of Tachpyr—a novel metal chelator
Samuni, A. M., Krishna, M. C., DeGraff, W., Russo, A., Planalp, R. P., Brechbiel, M. W., & Mitchell, J. B. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00218-0 · Cited by 28
Khanna, V., Karjodkar, F. R., Robbins, S., Behl, M., Arya, S., & Tripathi, A. (2017) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.181182 · Cited by 27
Song, B., Zhang, H., Jiang, L., Chi, Y., Tian, J., Du, W., Yu, B., & Han, Z. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv085 · Cited by 26
Nishitani, S., Noma, K., Ohara, T., Tomono, Y., Watanabe, S., Tazawa, H., Shirakawa, Y., & Fujiwara, T. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3640 · Cited by 25
Mei, Z., Yan, P., Wang, Y., Liu, S., & He, F. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8944 · Cited by 23
Lizier, M., Anselmo, A., Mantero, S., Ficara, F., Paulis, M., Vezzoni, P., Lucchini, F., & Pacchiana, G. (2016) · Oncotarget · doi:10.18632/oncotarget.11508 · Cited by 22
Wolfinger, R. D., Beedanagari, S., Boitier, E., Chen, T., Couttet, P., Ellinger-Ziegelbauer, H. C., Guillemain, G., Mariet, C., Mouritzen, P., O’Lone, R. B., et al. (2018) · BMC Biotechnology · doi:10.1186/s12896-018-0415-4 · Cited by 22
Serum Ferritin Levels in Patients with Cervical Cancer
Ito, H., TAKAGI, Y., ANDO, Y., Kubo, A., Hashimoto, S., TSUTSUI, F., & Kurihara, S. (1980) · Obstetrics and Gynecology · doi:10.1097/00006250-198003000-00018 · Cited by 21
Yanatori, I., Yasui, Y., Noguchi, Y., & Kishi, F. (2014) · Cell Biology International · doi:10.1002/cbin.10403 · Cited by 18
Kir, D., Saluja, M., Modi, S., Venkatachalam, A., Schnettler, E. K., Roy, S., & Ramakrishnan, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11689 · Cited by 16
Luo, G., ZHOU, Y., Yi, W., & Yi, H. L. (2015) · Oncology Letters · doi:10.3892/ol.2015.3011 · Cited by 14
Luo, G., Zhou, Y., Yi, W., & Yi, H. L. (2021) · Oncology Letters · doi:10.3892/ol.2021.12504 · Cited by 12
Corral, V. M., Schultz, E. R., & Connell, G. J. (2019) · RNA · doi:10.1261/rna.072371.119 · Cited by 9
Jiang, J., Wang, S., Zhang, L., Lu, J., & Yi, C. (2018) · Yangtze Medicine · doi:10.4236/ym.2018.22006 · Cited by 8
Cited by
Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model
Pei, Z., Qin, Y., Fu, X., Yang, F., Huo, F., Liang, X., Wang, S., Cui, H., Lin, P., Zhou, G., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102509 · Cited by 269
Iron Metabolism: State of the Art in Hypoxic Cancer Cell Biology
Liu, S., Cao, X., Wang, D., & Zhu, H. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109199 · Cited by 31
Metadata
- Authors
- Brown, R. A. M., Richardson, K. L., Kabir, T. D., Trinder, D., Ganss, R., & Leedman, P. J.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-04-09
- Volume
- 10
- Pages
- 476-476
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3015635259
- Cited by
- 278
- References
- 246
- FWCI
- 18.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.